Novel transcript, antisense to renalase (RNLS)

The "novel transcript, antisense to RNLS" (Ensembl gene ID ENSG00000289952) is a long non-coding RNA (lncRNA) that is transcribed antisense to the RNLS (renalase) gene. Antisense lncRNAs are regulatory RNA molecules that modulate the expression and function of overlapping sense genes, typically through mechanisms such as transcriptional interference, epigenetic modification, or mRNA stability control[1][2][5]. While many antisense transcripts influence disease-relevant gene regulation, there is presently no direct evidence linking this specific transcript to human disease or therapeutic intervention. Such non-coding antisense RNAs are increasingly recognized for their general roles in fine-tuning gene expression and may have future utility as biomarkers or drug targets if functional relevance is established[2][5].

Other names

ENSG00000289952Novel transcript, antisense to RNLS

Epigenetic silencing (e.g., through DNA methylation and histone modification for other NATs) Transcriptional interference (competition for RNA polymerase II, occlusion, or collision)